T. Nicklee

发表

A high-resolution MACROscope with differential phase contrast, transmitted light, confocal fluorescence, and hyperspectral capabilities for large-area tissue imaging

B. Wilson, D. Hedley, P. Constantinou, 2005, IEEE Journal of Selected Topics in Quantum Electronics.

Clinical studies.

G. Pond, A. Oza, J. Dancey, 2000, Women alive.

Multiparameter fluorescence mapping of nonprotein sulfhydryl status in relation to blood vessels and hypoxia in cervical carcinoma xenografts.

D. Hedley, T. Nicklee, V. Vukovic, 2002, International journal of radiation oncology, biology, physics.

Trialwith Pharmacodynamic Endpoints of the Proteasome Inhibitor Bortezomib in PatientswithMetastatic Colorectal Cancer

A. Oza, D. Birle, D. Hedley, 2005 .

Up-regulation of the redox mediators thioredoxin and apurinic/apyrimidinic excision (APE)/Ref-1 in hypoxic microregions of invasive cervical carcinomas, mapped using multispectral, wide-field fluorescence image analysis.

D. Birle, D. Hedley, T. Nicklee, 2004, The American journal of pathology.

Hypoxia-inducible Factor-1 (cid:1) Is an Intrinsic Marker for Hypoxia in Cervical Cancer Xenografts 1

D. Hedley, T. Nicklee, H. K. Haugland, 2022 .

Hypoxia-inducible Factor-1 Is an Intrinsic Marker for Hypoxia in Cervical Cancer Xenografts 1

D. Hedley, T. Nicklee, H. K. Haugland, 2001 .

Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer

G. Pond, A. Oza, J. Dancey, 2006, British Journal of Cancer.

Wortmannin inhibits pkb/akt phosphorylation and promotes gemcitabine antitumor activity in orthotopic human pancreatic cancer xenografts in immunodeficient mice.

M. Tsao, D. Hedley, T. Nicklee, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Effects of the Epidermal Growth Factor Receptor Inhibitor OSI-774 , Tarceva , on Downstream Signaling Pathways and Apoptosis in Human Pancreatic Adenocarcinoma 1

M. Tsao, D. Hedley, T. Nicklee, 2002 .

Differential effects of depleting agents on cytoplasmic and nuclear non-protein sulphydryls: a fluorescence image cytometry study.

D. Hedley, T. Nicklee, M. Thomas, 1995, British Journal of Cancer.

A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas

G. Pond, A. Oza, D. Birle, 2006, British Journal of Cancer.

The Association of Measured Breast Tissue Characteristics with Mammographic Density and Other Risk Factors for Breast Cancer

Norman Boyd, Ming-Sound Tsao, Trudey Nicklee, 2005, Cancer Epidemiology Biomarkers & Prevention.

Predictive and pharmacodynamic biomarker studies in tumor and skin tissue samples of patients with recurrent or metastatic squamous cell carcinoma of the head and neck treated with erlotinib.

G. Pond, J. Dancey, M. Tsao, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effects of the epidermal growth factor receptor inhibitor OSI-774, Tarceva, on downstream signaling pathways and apoptosis in human pancreatic adenocarcinoma.

Ming-Sound Tsao, David W. Hedley, Trudey Nicklee, 2002, Molecular cancer therapeutics.

Angiogenesis correlates with vascular endothelial growth factor expression but not with Ki-ras oncogene activation in non-small cell lung carcinoma.

M. Tsao, Ni Liu, F. Shepherd, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Effects of the epidermal growth factor receptor inhibitor OSI-774, Tarceva, on downstream signaling pathways and apoptosis in human pancreatic adenocarcinoma.

Ming-Sound Tsao, Trudey Nicklee, David W Hedley, 2002, Molecular cancer therapeutics.

Effects of topoisomerase I inhibition on the expression of topoisomerase II alpha measured with fluorescence image cytometry.

D. Hedley, T. Nicklee, M. Crump, 1996, Cytometry.

A Phase II Trial with Pharmacodynamic Endpoints of the Proteasome Inhibitor Bortezomib in Patients with Metastatic Colorectal Cancer

H. Mackay, A. Oza, D. Birle, 2005, Clinical Cancer Research.

Microregional heterogeneity of non-protein thiols in cervical carcinomas assessed by combined use of HPLC and fluorescence image analysis.

D. Hedley, T. Nicklee, V. Vukovic, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Relations between non-protein sulfydryl levels in the nucleus and cytoplasm, tumor oxygenation, and clinical outcome of patients with uterine cervical carcinoma.

D. Hedley, T. Nicklee, A. Fyles, 2005, International Journal of Radiation Oncology, Biology, Physics.

Association between tissue hypoxia and elevated non-protein sulphydryl concentrations in human cervical carcinoma xenografts

D. Hedley, T. Nicklee, F. Moreno-Merlo, 1999, British Journal of Cancer.

Differential effects of buthionine sulphoximine in hypoxic and non-hypoxic regions of human cervical carcinoma xenografts.

D. Hedley, T. Nicklee, V. Vukovic, 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

MACROscopic imaging of tumor xenografts using fluorescence, phase contrast, and transmitted light

Brian C. Wilson, Paul Constantinou, Savvas Damaskinos, 2004, Photonics North.

A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas

G. Pond, A. Oza, D. Birle, 2006, British Journal of Cancer.